0001493152-23-046152.txt : 20231226 0001493152-23-046152.hdr.sgml : 20231226 20231226170012 ACCESSION NUMBER: 0001493152-23-046152 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231222 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Viveon Health Acquisition Corp. CENTRAL INDEX KEY: 0001823857 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39827 FILM NUMBER: 231513880 BUSINESS ADDRESS: STREET 1: 3480 PEACHTREE ROAD NE STREET 2: 2ND FLOOR - SUITE #112 CITY: ATLANTA STATE: GA ZIP: 30326 BUSINESS PHONE: 4045797978 MAIL ADDRESS: STREET 1: 3480 PEACHTREE ROAD NE STREET 2: 2ND FLOOR - SUITE #112 CITY: ATLANTA STATE: GA ZIP: 30326 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 22, 2023

Viveon Health Acquisition Corp.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-39827

85-2788202

(State or other jurisdiction
of  incorporation)

(Commission

File Number)

(I.R.S. Employer
Identification No.)

3480 Peachtree Road NE
2^nd Floor – Suite #112
Atlanta, Georgia 30326

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: (404) 861-5393

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Units		VHAQU		NYSE American, LLC
Common Stock		VHAQ		NYSE American, LLC
Warrants		VHAQW		*
Rights		VHAQR		NYSE American, LLC

* The Warrants trade on the OTC Pink Marketplace maintained by the OTC Markets Group, Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On December 22, 2023, Viveon Health Acquisition Corp. (the “Company”) received a letter from the NYSE American LLC (“NYSE American” or the “Exchange”) stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Common Stock, Units and Rights (collectively, the “Securities”) pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that the Company specified in its registration statement. At this time, the Securities have not been suspended and will continue to trade.

As indicated in the letter, the Company has a right to a review of the delisting determination by a Committee of the Board of Directors of the Exchange, provided a written request for such review is requested no later than December 29, 2023. The Company intends to make such request.

Cautionary Statement Regarding Forward-Looking Statements

Statements contained in this Current Report on Form 8-K that are not historical facts may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements do not constitute guarantees of future performance and are subject to a variety of risks and uncertainties. The Company does not undertake any obligation to update forward-looking statements as a result of new information, future events or developments or otherwise, except as required by applicable law or regulation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: December 26, 2023

Viveon Health Acquisition Corp.

By:	/s/ Jagi Gill
Name:	Jagi Gill
Title:	Chief Executive Officer

EX-101.SCH 2 vhaq-20231222.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 vhaq-20231222_def.xml XBRL DEFINITION FILE EX-101.LAB 4 vhaq-20231222_lab.xml XBRL LABEL FILE Class of Stock [Axis] Units [Member] Common Stock [Member] Warrants [Member] Rights [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 vhaq-20231222_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Dec. 22, 2023
Document Type	8-K
Amendment Flag	false
Document Period End Date	Dec. 22, 2023
Entity File Number	001-39827
Entity Registrant Name	Viveon Health Acquisition Corp.
Entity Central Index Key	0001823857
Entity Tax Identification Number	85-2788202
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	3480 Peachtree Road NE
Entity Address, Address Line Two	2nd Floor
Entity Address, Address Line Three	Suite #112
Entity Address, City or Town	Atlanta,
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30326
City Area Code	(404)
Local Phone Number	861-5393
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Units [Member]
Title of 12(b) Security	Units
Trading Symbol	VHAQU
Security Exchange Name	NYSEAMER
Common Stock [Member]
Title of 12(b) Security	Common Stock
Trading Symbol	VHAQ
Security Exchange Name	NYSEAMER
Warrants [Member]
Title of 12(b) Security	Warrants
Trading Symbol	VHAQW
Rights [Member]
Title of 12(b) Security	Rights
Trading Symbol	VHAQR
Security Exchange Name	NYSEAMER

XML 7 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001823857 2023-12-22 2023-12-22 0001823857 VHAQ:UnitsMember 2023-12-22 2023-12-22 0001823857 us-gaap:CommonStockMember 2023-12-22 2023-12-22 0001823857 VHAQ:WarrantsMember 2023-12-22 2023-12-22 0001823857 us-gaap:RightsMember 2023-12-22 2023-12-22 iso4217:USD shares iso4217:USD shares false 0001823857 8-K 2023-12-22 Viveon Health Acquisition Corp. DE 001-39827 85-2788202 3480 Peachtree Road NE 2nd Floor Suite #112 Atlanta, GA 30326 (404) 861-5393 false false false false Units VHAQU NYSEAMER Common Stock VHAQ NYSEAMER Warrants VHAQW Rights VHAQR NYSEAMER true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 5 25 1 false 4 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://viveonhealthacquisitioncorp.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm vhaq-20231222.xsd vhaq-20231222_def.xml vhaq-20231222_lab.xml vhaq-20231222_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "VHAQ", "nsuri": "http://viveonhealthacquisitioncorp.com/20231222", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "vhaq-20231222.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "vhaq-20231222_def.xml" ] }, "labelLink": { "local": [ "vhaq-20231222_lab.xml" ] }, "presentationLink": { "local": [ "vhaq-20231222_pre.xml" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 5, "entityCount": 1, "segmentCount": 4, "elementCount": 67, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 33 }, "report": { "R1": { "role": "http://viveonhealthacquisitioncorp.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-12-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "VHAQ_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://viveonhealthacquisitioncorp.com/20231222", "localname": "WarrantsMember", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_RightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightsMember", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Rights [Member]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "VHAQ_UnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://viveonhealthacquisitioncorp.com/20231222", "localname": "UnitsMember", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Units [Member]" } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://viveonhealthacquisitioncorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001493152-23-046152-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-046152-xbrl.zip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

S@\1M*&CV,I3-#7X;"MIBRVIVD)D$>$[2_=+M+VY0Z-+%>\?W MMF&YKQ 83X4IUXD-5ATUJ-GA"W>6,!WE2EFJ%&V]=U ?"/_03)0^0H<73DP1 MLKG!#F-D[L+65BC$,(, MIL6>JUQ/.#27?][Y<4C4QXARO!W$RT/YJ7XB88VVF'%DX5"/Z,,=<5+2>TD= MYY%<*EV:MX."+@O%XUFV.XXAP7YMC"(P_T2ZA*!#!^(W)!,%>T&C]Z8!!H&E M9SEC#,OIL!,:0$!DQP*\+(NQ2V87#3-FLOA1,U BC?A54I8W*&DT!/F\!SQD M#-* 3>*D!UF'4,UD>U39G'E!+8=H>1\;=D!&8%X=I86L%KL^BWHQ[&B./92M MZ3MS@B%&4('UTV!R055WIK-U+=PC/)*6"8%>#D#E031C:5_3=1Y;,JO(><-S MW9&%6(BQU5FFN2E8FQM>FPXWR(U[IH@K/@3D<#8V.;5)R..9D:V!FG$S#JB]. 8$Q8UX/R ML7P%EP$7"8XJ]N='!;>*!Y< 6 M,Y%S>;_\^0VJD>B+&HG%7@R)'3;;F XW-T;?!9EYA6EF,E$Q:1]^#9^:9IO] M/6IC+?N\Q\]DQ*>M$CZ%FO$<;6XP&X>]SR/<5KI7@7IW'(*FCX[UXX884V$U MH2VH-UO.@PM1P AW\!!,*=-@)A%(=R5B9(XMSWLP8] AV. K4FX;-CQAJA&;GSI(-:LM/+\#S2EC M'N;JW)] M?:+TIZ1(?/=JBX^2W(&X;N9-51 BXKCR?\U4'7V(>$"JBJ6'.-&9.4=81UA M#[PP180GDQ;6&^"R1'#-/:O; GP<<0P6OS-XL%Z%Z!'05S_!?_WULL%NB59S MFQOC6"SMW1.]^KQ?S33[9$8=@#&2OH>D#^ 9?";(@JVY=QDTPWC^A=#+/,!E MN?7"7^MZ1U?T4I]]5,V[,4Q^?113L26C^)5$9Y&4%H>Y%V=B<><:+=16:?FH M%17('N.FA@XU7=^/:JNP:>%/E216ZI]S,?EJL\!D1" B!.6+H??W" G?M?:R MQ?D=:)5:&FFX=Z).71A&OQRR+TG+:G_J?SD/F-A#YUW^O36'3MF=0^NTX"MI MP;\T(_?I&X^BLJD.F=)%6W9'S_O%N$X (>XNCE*2\?=CG3; MJ5W\/'7TBZN3Q.#HL"J5KN_J-3G9N_M&:C^>:U+5)+<_SNXN6M&3 L6F%/N9 M;A6/$[A6N3DL/J>^:9T#Y9@D;S,I&=\/K.)SR>@?%IN[#BX-A\5R.MY.T8.+ M9K*-RT[SCOSL]4FEY=RI1]WSGT_J4ZVR>UQ\JG>3RFT=#V[3&$>SK1,ITRY5 MLH^W1SU\'-/*&;D6B^]^*_RL# M*-J;;V?9C/WU2[32.3X_395H?JI)3Q/>/ M0_QH7NG-9UIV?NY^HU%-3CN7F30>W'Q+UA*'V:L&/CNCU\G[9IH ,XKJT5,A MVW52MV?*C[/,I2E7\/5)SWBBC\5:?[=:Z1X6:?]G[6=;MG\$ MG-&Y5/>Z$_8CJLR)U75XE^O;AFWR8@WJ1]*N;Z MCJ;O?Q]]Z?Q[\L^;(=Q/9W?O6Z-(_-E_#'7T]_3UI_.3R?B/F3^X/3O+379U M.(68$KP,H7N.C:\(;]YN2#7Q_&:SY7V[NAQF."<'!@O.Q/TF>*O3Z7C9;@FM M(1&VY[=MAS?;;;==JMDWGX\^ZLBS=@,I)@"Y69*PX>4:6:P8$*I$IO@ MF MIOPHZI-_NYB%O#S;VJ&7M7L-8Y+5?& 3K>=H9KNN4\BF"L8]9S:E#VYYQ=\Q M[ ;F8 FQ%G;4?'9'ZR=5&"Y54!76M-1Z$BJ1"2C#L(26&D_N.C.6_F7)#+%V MM$.\7Q@YIZ-#(T<*\&<,^=+J?XY8,+I& YSHN0= MX<261W.3?;T-;A=9,NUK=,OCN]/H1HX'W.A2V"1J5VKYHQ^T ^R63T=>LK4>I MRKS#02[_+L?+()(Q96)@(+9(C"8=:>RHJ45_4#+%*3A7QQ"RR\D[JA05ZW[6 MI/^OJUTOOQU<_@=02P,$% @ !HB:5WY%6^H5"0 _6H !4 !V:&%Q M+3(P,C,Q,C(R7V1E9BYX;6S57=URXC@:O=^J>0TT(9#*[G>GL%$TGL]1T M=S(AW;V[-Y2P!:@B)$:2";S]2OXA-M9GFTRBV+E(C#F2CLZ1)7VVY+S_=;NB MW@8+23B[[/1/3CL>9CX/"%M<=KY.NL/):#SN>%(A%B#*&;[L,-[Y]5\__,W3 M/^]_[':]:X)I<.%]Y'YWS.;\%^\+6N$+[S?,L$"*BU^\;XB&Y@R_)A0+;\17 M:XH5UE_$!5]XYR>#4^1UNS7R_899P,77N_$^WZ52:WG1ZST^/IXPOD&/7#S( M$Y^OZF4X44B%$/5R87S,DL:?U8O)B*\EEQY2;%/MX=L+% MHCWW_O/YT\1?XA7J$F9T\W$G365RL:7KOWOWKA=]FT(+R.U,T+2,LUY* M9Y^S_C90^P19\'DO_C(+)2599TA+S1'_J @=G_<%@8(K[>PZD=FO=K"4QK;+C]7)4D/!3 M-C9PMA2@XJG^IL;G4>%+G87PPQGN!F2%F;D".EY24+:Z^UP(4ST-[268GC6# MU^>]+ZP;\!4B1Y(NIG; ."JIN\*KF;'[*+KYI*_/%5%Z',,HP>OS8EP-CZ66 MIG':)O$EB#+ID[&G M[W7-0!5J>DH?QLB$6FHNBDC*58([D+-(AE-T%0NN>Z11[F"J9 MGHFZR4C9Y,34#(_8T- "X+$^E&D!%,TPC8J=)F ;MO>VK._1[*EQE3!.<(=L MG_P?BI1WTGAJ7J%QB[WP.5.ZQ5S1J#3=ZO'"'*3,YH*O*J5,9..E-+66_F2I?@Q&:@A0VS8%W6B.&>HL@%4F%=!4]NUU A% :Y@G_!F#?J.+)8EFB>P+&KZ4U-%A\A"JO_T(JI+[)\L^*87 M8!(+K@^>=-8?IFFL=*]SM&BL(5G$].>WT;=Z4F\C"FG[(O.2:FF'FDQ@"%U3 MM+!KFX,T6MPBTU>=@1^A[DUB2--J&:.3A@NG5CR%B(Z!U>M\3WA.N(?HENAOI4T)/_/;N6?+#&EYD$T8K5: M?Q'?"@L VI )_W@[$ZXV9J*@JU;?AWV2UEF19PZY\4^W;MQB07B@ZR1J^' M;H4#-LZ0]N_>0OLK%M15/H&V2/4?1;$SM'FW'@:X$F9-XK72U 4"2%OA0QARTPU$X&S,<1TLM>>9^]XB' M^JK=C7A0.@24)FR!-=7\08, C,@UN #,$?Q M+\1N<)P%@U9:,"BWP%'\"[$[.\Z"LU9:<%9N@:,H.,=NI ]OQ#U_!)Z^ ^#V MR'_ &13?:0B<<(MJ.M9E0,'*=IC@XTXZ(73,#EM)_%TH8V"K3L*@=IM-9% MIJ"\CD)C,^8,!49PL\XBFBWN(5%06T=Q[B=NGNHL.2N]AWR(:K3&5K*@SJ[" M5;/-4X+=P_[K1BN;9PE)^NQM,T=*^ET0I?F8O1 A2^X@ 4_^K-!&2PTS!F5W M%').."6^5H@M/NMZ"(*H7?,BKM&" W1!M1U%E[<"FS: ]20_6@QG]HJ+F_D< MZJEA?*/5KZ -NN HS#R@-Y8RQ.)8+PJIVN2(G3SHBZ.04N_Y@=F]> M? #T1 >H1NMN)0OJ["C,_,+O!3)OO%'"'H"I5L\VH0Q[TQ>ES MTN^8TM\9?V03C"1G.(@#B[*G%4"21CM2S1RTP^F3TV^H@5>E! 'O7"Z\#BZ4$>Z/@M>OG8@!VR!\D6^H.!.UQM/5HC2#Z'4%9"E M_4\.V +!BWQ!P9VN*+Y:8;'0W>!O@C^J9;*1MTQX:X(6& #S!HUPNG+X:OOT M8H%X5V.I"P5T&RRPDX;T/W>\;7;H^V:I23PG8 $2@ ,POM$>5- &77 4)M^H M)1;965E$S52F;"%(5:I&.U*+/.B+TS Y^YJ'TF$Y@VNT]@!=4&VG4?!M.*/$ MOZ83[ ;$'$:Z5O[L5W,?8/!B2^VNR1O!5*X,6V%._ M'J!Q;K?B/KUR=K)$ LN;4$7_ST>S+;UQ49*N!395T@?=(Z%6;QQC[?J@R[HH7QR59F\T5X=5PO0LDSH_;YW4$%=_(/^+CEO?IE_0*3/ M_!]02P,$% @ !HB:5T@F447V"P ZY( !4 !V:&%Q+3(P,C,Q,C(R M7VQA8BYX;6S-G>]OV[@9Q]\/V/_ >6\VH(X3!QO07'N'-$UNP:5)+DY[VXJA MH&7:$2*3&24GSG\_DA)EB>0C*>F-9%^TKOA]J"_%CTCJ!ZEW/VW7&7HD/$\9 M?3\ZV-L?(4(3MDCIZOWH\VQ\/#LY/Q^AO,!T@3-&R?L19:.??OSC'Y#X\^Y/ MXS$Z2TFV.$(?63(^ITOV [K$:W*$?B:4<%PP_@/Z@K.-W,+.THQP=,+6#QDI MB$@H=WR$_K8WW<=H/!Z0[Q="%XQ_OCFO\[TKBH?\:#)Y>GK:H^P1/S%^G^\E M;#TLPUF!BTU>Y[:_W:_^E.'OLI3>'\F_YC@G2!POFA]M\_3]2.ZWVNW3X1[C MJ\ET?_]@\L]/%[/DCJSQ.*7RN"5DI*-D+JZX@[=OWTY4JI9:RNV<9WH?AQ-M MI\Y9I*8=^H:3/#W*E;T+EN!"57OO;A"HD/\;:]E8;AH?3,>'!WO;?#'2!U\= M0R+O,M^,]&[[DKSNB._B_!]IT=>XL:>6;R=:<<;OLLF=4>2YQ/E<9;_+Q M"N,'L8/IX81D1:ZWC.46=1"J#=]DWTC6A!8G&<[SJ^6L8,G]\3;-]7Y4(=^/ M!N@G9@%DY#'7I< \Z3D4E6*2,-&1/13CK#SH9?B2L_4@&]4Q8P/$W[)YG7]Y MD(4%H" M&2E0KA^M,1,@!&Z'CS[/1CTJ&V!(I(?HJI?]Y M-]EE_1J6'N_P?Q4@!]/I5$'RY1_'OW[[3-,B_T36<\(-]W:R#P0@4[+&S;3@ M%0P8,NM3*=#74O/=%?G=C8(8OZ\956PY*[Y#Y[,1 &TV3WY+%)R)/F?6R:YT M^E3_G1@!3O;?,.>8=IWOIL+;*>^V5I_U[>3@E0Q[,JM7B^(Y_6_2U1V @%OB M\Z1WF6N>[\WTX!1TF#(Q*"7Q0% /26[Q?#?BAL8ME2C($+!ET#GN4XIH8'#: M,G&H1>BKDD4$A+CB(>?B9^\E0D,8! S+J!..6A4?(*:U#DBD%"GM[TM*3I*] M%7N<+$A:0B)^[-@0__GVD24;1;/(T2B0G>R# \B4K'TS+7B= X;,FM82)#6> M*_A8['@A=WZ6X97#OI'NJXJ=MG0=MQ*CJ&27([.6:PV2HE#5_)'D"4\?Y).# MKG*T9-XKW6'2JON&)BX$;&,P"0UMH(;]AJS2O.#J45+=XW0T8X#>=]/?:=OL M"YSB** 9XA#L+9I!J(X*Q-$QI1N>Z&PE+ZY *R::!BRJ.AP>P,!J>5A&;GEF.:I;,!Z(;&E MWB\W +/6I8>ABXH3P!Q\25+KPY(RNR-9)E\]PK2_07&)?=,"&S9YL951$0/: M YE1$:@*B0>;TTA#PF/9[N*G%D>+D.EP($4J#,FX0"0UWGCJ M8CD3V\S'*SU:WX" =DU(+&%4H$#N0%C* ,V,"@D*S+\(YL-P M:2C#P&)9=:-2RR($Q?36AXG4!X'D9,-YRS7=+@<4Q97X)<)ML4]#61$2"TQA PTZKIJ\%(>)$M$P<9^=T0;:_D&>P M7);.+Q. S384AB@B*MS. "PJ,5)J).1!P+CFZ1KSYUF:]'05MM O&I#1-ANF M*B(X &L '94:SX M?BKE&_T#R1AT16.!9OJ"HD[#0S,="LTT:FBFKX'F]HE% LWA"XIZ&!Z:PZ'0 M'$8-S>&KH!$5'[2M.1$_K_@M>W*]G TJ@R!C6W4"LY/%AXOEK0\6&2#',S(D M)"9J8'7%KSE[3&D"#YDA>1!@ --.:@QM?.BX#?;Q4P^(=5S0MJ8>)%H6 MII5IFW0W,:4F/DC:QGH;EU(=$HEKEA^>E"+?U2P9 MY00#+4([V5LE.TS5==Q(BZ.*;4-6#:OS6FA"G,AR(+F:7NYOO1IJWGMVT4W?D.B&*VC7=6-VT3O=< MF[_QM!![E@M*;6CUE,?UWB"@\U7+G39UC3M%4=1^ES-K\:=2B]IBSUC,6)8F M:9'2U2=Q\UW.6 :M/.56^(.BPJ#EP M2*) ?9ETG#)4"5%I3;$ZE0MLX[B&.F^ '#:TE7?2HRBTEV.K)._5=>!FOS3 M;7(G3!%@0H);YKOI=YDTF_^F)@H$.HQ9%R65%&EMB D)NRYKU3\(6 4;!*QZ M!@&K& ;;E$B&B7KN99NL+ XH2=:M]0=%@V^7!(HT(%]@>V M&74(VL7X7M%2+7$FOP3&UVK_9^*'HY2 SMN:EETVZT4M7:(H&.ER9BUK62XZ MUQ CJ?;-Q6:1%F11FCE+*:9)BK-Z>437'?'^$&^T##1?@].CCX.A828MG,HP MO99A';A;ZM+WK?3R!8S?2);]0MD3G1&<,TH6Y;T4UY.B;KW?-V9Z;+=?F@'$ M4> TQ"'PZHP,&M_+**3#JCMA04CZPK(-+3!7<\FYJV4"='[) 6RVB3%$$9'B M=@804HM1J0XS0;M9)6?. 4+",D]3]?N-&W,VG9J(V*FTR TA[M:\V,W M-BZC DVQ+ C'29$^DH^XP)4WL+R0W/>DRB[3YFQ*ES8BA#H-@O,GZQBY5 S6 M3 5;,H:?B*'6BG6\)6ZH_"\<8UFTUXZI)1'AX?+5L8(,1UH;A(79&F?9ATV> M4I+#'9&A\LN"TV*;A98D(A9$KT3W]C-G3\5=M3XK6#9 M[9>-3LMM1IS2B%CI\@NW!WR&I(Y .\4S-E6"8-Z_CE GY+3UPMD-_B"^" MAIK7'/7IHZ!IH$F3*176OKA6@>J[B"%7,VHN;@\/\5HBSR-CAT%C8-Q01,$( M: L:%C>_%1!F[;S-/$N3LXQA^"Y+2^-YQ3S;GK%8WDX0$0&V*VB)/"5$2AFD M_C]@>L\W#T7R?,U90HA\RRJO6ZN^^V\#H_TR\Z(BM6D:%!H19R_Q"Q"XRP(U M\GC3Z+%"WLR3+XW+U=Q8C9@9H+M\1J[) 7V4F2.7B^GYY<].%^"4V MZTWBKSG.B=CR/U!+ P04 " &B)I7^V"U/UD( "/90 %0 '9H87$M M,C R,S$R,C)?<')E+GAM;-6=;7?:-A3'W^^/O28$LJ>FS792FFRA$2$R2"7S[238F@"WYLFY?%+\L9CQ94 M:2;%1:M[#5J0-$0GA4M"+EI"M7W[^^JO(_GOQ M3;L=73/*D_/HE8S; S&6SZ-W9$;/HU^IH(H8J9Y''PE/W3ORFG&JHKZKO_ES5]P)A[.W8\1T32RO(0^7VIVT7+[7>_V\>Q$JDFG M=WK:[?S^]LTPGM(9:3/AN,6T5;1R6ZEJUWWV[%DG^[20EI3+D>+%/LXZ13B; M+=M/64"_%8EFYSH+[XV,B[VVF?=DZ5.6@7\C*"2 MG-[1<>3^M]G;['7!%E2**27<3$G\5\HTFYWW^Z(S&IN^ZIFKJNUHLY.*'-%-14F<__&OK'3A"Z- M[6$T*3;D]O\%P1IF7/MUE^I&;=?_TIG=O7V9*]>Q%=%Q&>\$Q%V>Y)[[HL]G MV= T/IG(12>AK..(N!<9F@R+_>5SMJ/+D3:*Q*;8$B9*']'?_SM\OWG#X(9_9;. M1D]?DUM@G61'48=SRW950.#?HW??*G/_ M*O'Z^J"H2>[M%JO+@UT%D.U_A=9_VEJ@+46,@O72[C]Q,5QS,JGFNBKW57H@_Q\;P=]ON $9 MN%JXDP'K!IZ$K2; //S4N#R4;".EXI8J)A-K0P&24!(#\3]K!'Z/553P5R*! M8M](P055@ZCO^41B?LUT3'@>T;5]K^J6Q%;H%7(H>]QJMM8O*O\_*%%@^EMB M*'O< K?&ZY')]U.E=H()#CA^-90];FE;Y_;(\*^$86;E9@B]2SV7>:VLK(+" MQBUG?>Y0(!<7,X1Q,Z!"H/>54-BX56S()0KPO@U8$3X0"5V^IJL0\9(4BARW M>@WZ1&%^J]B,J-60Q?7C25D+I8Y;LX:=HF"_)\M!8L-F8Y9/+ZRG[VT"30)N MP0KRC9*+038Q46Y=M>[+U!ZAJ[Y,@L-^34-H7G KV0,8H&3G,DDL-[W^SSGI MAG)2*0??Q6I )@)^&\*_=QC_'IP_;H5;Z[3?MR]O MU+U\]-P^]XJA['&KW!JOF.2S^&_4K9(+EJ_-J,-?:@'-01.*W[!KU$,@/R. M]/]""07?A$*XVB4F\%NI#>%_LGG=B6BU'@J_"25QR/&Q+V_F'+OT+L**%G-(>[M"[[^?(/#\I9FP$;EU"*M;7@SPW\#Q2*&?EC5M&^AT>&?6MHB[EU)Z^9S/6W'II=3,> M^T;GD!Z*'K>*K'>,FX*!UBE5AR:BHA4T';@%)=3]L8<@&J=V1%QU>Z-[M^S? M,P"55%#HN,6DS]V1(;^3]XJXYY,,5[.1Y/Z5-95"*&K$K$A/HG8U0KH:1Q:\B02[3Q>0(:GR<'CL^XM:3/'1+D M?.Z\/<9N1IQ-B']]7K !>*U2(] '/!][>62V;,H]YDK-LCBN[8MJ_AXIE#SR M4M20SV,S3Q-F:)*'=,T$$;&MT38V/!< ZEM!,X&\5A7H'N6^PR?*^6LA'\60 M$BT%3?*2(73KP=L$FHXFW/>L\8V2BX^2IQ:7RF;#*L]1X9%"V3?A?J?')\X$ MU'RN]^;[*7_F80B]KP4T TVX\1EVC30ESU#WA#BVH*^((>L(0XGPM8 FH@DW M0<.NT18:J+YU,)'A._][0BCV)DP,KO2(0GLX(YR_3+4-60>'G3TAE'839@!7 M>D2A?36C:F+'NU^5?#33]1K:$'5/ RC])LSS#7K&R<+R:2E_OJHPF((*-?B1 M$4W@[W6+]724.';S0O*O?9$0Y<$?TD,3T(P%K'['1T[!C9E2M7W6E07CP@_- MX:AO!4T';B$,=8_S1;SU5(7@]_".#@J^"25OE4.IR?[*A(TO>%TBV Z:HR84Q1 "2.=.^FG5'$U>KN[HF"HWV>*>+LU+ MNZ.'\*D4H#DT4&UL M4$L! A0#% @ !HB:5T@F447V"P ZY( !4 ( !WB, M '9H87$M,C R,S$R,C)?;&%B+GAM;%!+ 0(4 Q0 ( :(FE?[8+4_60@ M (]E 5 " 0